Clinical impact of radiation-induced myocardial damage detected by cardiac magnetic resonance imaging and dose-volume histogram parameters of the left ventricle as prognostic factors of cardiac events after chemoradiotherapy for esophageal cancer.

Rei Umezawa, Hideki Ota, Hidenobu Takagi, Noriyuki Kadoya, Yujiro Nakajima, Noriyoshi Takahashi, Takaya Yamamoto, Kei Takase, Keiichi Jingu
Author Information
  1. Rei Umezawa: Department of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1, Seiryou-machi, Aobaku, Sendai, 980-8574, Japan.
  2. Hideki Ota: Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine, 1-1, Seiryou-machi, Aobaku, Sendai, 980-8574, Japan.
  3. Hidenobu Takagi: Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine, 1-1, Seiryou-machi, Aobaku, Sendai, 980-8574, Japan.
  4. Noriyuki Kadoya: Department of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1, Seiryou-machi, Aobaku, Sendai, 980-8574, Japan.
  5. Yujiro Nakajima: Department of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1, Seiryou-machi, Aobaku, Sendai, 980-8574, Japan.
  6. Noriyoshi Takahashi: Department of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1, Seiryou-machi, Aobaku, Sendai, 980-8574, Japan.
  7. Takaya Yamamoto: Department of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1, Seiryou-machi, Aobaku, Sendai, 980-8574, Japan.
  8. Kei Takase: Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine, 1-1, Seiryou-machi, Aobaku, Sendai, 980-8574, Japan.
  9. Keiichi Jingu: Department of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1, Seiryou-machi, Aobaku, Sendai, 980-8574, Japan.

Abstract

This prospective study aimed to evaluate whether radiation (RT)-induced myocardial damage by cardiac magnetic resonance (CMR) imaging could be a predictor of cardiac events after chemoradiotherapy (CRT) for esophageal cancer and determine the dose-volume histogram (DVH) parameters of the left ventricle (LV) in predicting cardiac events. CMR imaging was performed before and 6 months after CRT in patients receiving definitive CRT. RT-induced myocardial damage was defined as abnormal CMR findings indicating myocardial fibrosis corresponding to an isodose line of ≥30 Gy. The cutoff values of the LV DVH parameters were calculated using the receiver operating characteristic curve based on the presence of RT-induced myocardial damage. The prognostic factors related to cardiac events of Grade 3 or higher were examined. Twenty-three patients were enrolled in the study. RT-induced myocardial damage by late gadolinium enhancement and/or an increase of 100 ms or higher in native T1 post-CRT was detected in 10 of the 23 patients. LV V45 was the best predictive factor for RT-induced myocardial damage with a cutoff value of 2.1% and an area under the curve of 0.75. The median follow-up period was 82.1 months. The 5- and 7-year cumulative incidences of cardiac events of Grade 3 or higher were 14.7 and 22.4%, respectively. RT-induced myocardial damage and LV V45 were significant risk factors (P = 0.015 and P = 0.013, respectively). RT-induced myocardial damage is a significant predictor of cardiac events. LV V45 is associated with RT-induced myocardial damage and subsequent cardiac events.

Keywords

References

  1. JACC CardioOncol. 2021 Sep 21;3(3):343-359 [PMID: 34604796]
  2. JAMA Oncol. 2021 Feb 01;7(2):206-219 [PMID: 33331883]
  3. JAMA Cardiol. 2020 Nov 01;5(11):1265-1273 [PMID: 32730619]
  4. Br J Surg. 2014 Apr;101(5):502-10 [PMID: 24615406]
  5. Acta Paediatr. 2007 May;96(5):644-7 [PMID: 17376185]
  6. Cancer. 2016 Mar 15;122(6):917-28 [PMID: 26716915]
  7. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):656-65 [PMID: 20159360]
  8. Int J Clin Oncol. 2020 Jun;25(6):1098-1104 [PMID: 32189155]
  9. Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):1013-1021 [PMID: 33577960]
  10. Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1444-51 [PMID: 20605341]
  11. Clin Radiol. 2014 Dec;69(12):1273-9 [PMID: 25246336]
  12. J Thorac Oncol. 2018 Oct;13(10):1508-1518 [PMID: 29883836]
  13. J Clin Oncol. 2017 May 1;35(13):1395-1402 [PMID: 28301264]
  14. Heart Fail Rev. 2022 Sep;27(5):1899-1909 [PMID: 35064397]
  15. Int J Radiat Oncol Biol Phys. 1985 Apr;11(4):801-8 [PMID: 3980275]
  16. J Am Soc Echocardiogr. 2013 Sep;26(9):1013-32 [PMID: 23998694]
  17. J Clin Oncol. 2012 Aug 10;30(23):2876-84 [PMID: 22802310]
  18. J Radiat Res. 2015 May;56(3):568-76 [PMID: 25755255]
  19. Adv Radiat Oncol. 2020 Aug 05;5(6):1170-1178 [PMID: 33305078]
  20. Radiother Oncol. 2015 Jan;114(1):96-103 [PMID: 25465731]
  21. JACC CardioOncol. 2022 Mar 15;4(1):19-37 [PMID: 35492815]
  22. Int J Radiat Oncol Biol Phys. 2015 Nov 15;93(4):836-44 [PMID: 26530752]
  23. Radiother Oncol. 2012 Jul;104(1):72-7 [PMID: 22682539]
  24. Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):10-8 [PMID: 20421148]
  25. Clin Lung Cancer. 2019 Nov;20(6):435-441 [PMID: 31303452]
  26. Gastroenterology. 2021 Dec;161(6):1878-1886.e2 [PMID: 34389340]
  27. Dis Esophagus. 2013 Jul;26(5):522-7 [PMID: 22925398]
  28. Radiology. 2018 Nov;289(2):347-354 [PMID: 29989523]
  29. Radiat Oncol. 2015 Aug 14;10:171 [PMID: 26269033]
  30. J Thorac Oncol. 2020 Oct;15(10):1682-1690 [PMID: 32599073]
  31. J Clin Oncol. 2021 Sep 1;39(25):2816-2824 [PMID: 34101496]
  32. BMC Cancer. 2015 Oct 27;15:813 [PMID: 26506988]
  33. J Nucl Med. 2006 Nov;47(11):1756-62 [PMID: 17079807]
  34. Strahlenther Onkol. 2016 Jun;192(6):359-67 [PMID: 26884226]
  35. J Clin Oncol. 2017 May 1;35(13):1387-1394 [PMID: 28113017]
  36. J Cardiovasc Magn Reson. 2009 Mar 03;11:5 [PMID: 19257889]
  37. Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):348-56 [PMID: 19735862]
  38. Radiother Oncol. 2022 Mar;168:75-82 [PMID: 35077710]
  39. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1580-6 [PMID: 22284687]
  40. J Clin Oncol. 2002 Mar 1;20(5):1167-74 [PMID: 11870157]
  41. J Gastrointest Oncol. 2015 Oct;6(5):516-23 [PMID: 26487946]

Grants

  1. 24890018/Japan Society for the Promotion of Science

MeSH Term

Humans
Heart Ventricles
Contrast Media
Prospective Studies
Prognosis
Magnetic Resonance Imaging, Cine
Gadolinium
Magnetic Resonance Imaging
Esophageal Neoplasms
Chemoradiotherapy
Cardiovascular Diseases
Predictive Value of Tests

Chemicals

Contrast Media
Gadolinium

Word Cloud

Created with Highcharts 10.0.0myocardialdamagecardiaceventsRT-inducedLVimagingmagneticresonanceCMRCRTesophagealcancerparameterspatientsfactorshigherV45studypredictorchemoradiotherapydose-volumehistogramDVHleftventriclecutoffcurveprognosticGrade3detectedrespectivelysignificantP = 0radiation-inducedprospectiveaimedevaluatewhetherradiationRT-induceddeterminepredictingperformed6 monthsreceivingdefinitivedefinedabnormalfindingsindicatingfibrosiscorrespondingisodoseline≥30 GyvaluescalculatedusingreceiveroperatingcharacteristicbasedpresencerelatedexaminedTwenty-threeenrolledlategadoliniumenhancementand/orincrease100 msnativeT1post-CRT1023bestpredictivefactorvalue21%area075medianfollow-upperiod821 months5-7-yearcumulativeincidences147224%risk015013associatedsubsequentClinicalimpactradiotherapy

Similar Articles

Cited By